CIB 1H2022 Condensed Separate Financial Results

RNS Number : 5292T
Commercial Intnl Bank (Egypt) SAE
25 July 2022
 

 Click on, or paste the following link into your web browser, to view the associated PDF document.


http://www.rns-pdf.londonstockexchange.com/rns/5292T_1-2022-7-24.pdf


Commercial International Bank (Egypt) S.A.E.

Condensed Separate Financial Statements

June 30, 2022




Condensed Separate Interim Balance Sheet as at June 30, 2022

 


Notes

Jun. 30, 2022

 

Dec. 31, 2021

 



EGP Thousands

 

EGP Thousands

 


 

 

 

 


 


Assets

 

 

 


 


Cash and balances at the central bank

8

41,845,093

 

43,385,222

 


Due from  banks

9

56,970,904

 

79,991,287

 


Loans and advances to banks, net

11

1,308,243

 

312,216

 


Loans and advances to customers, net

12

169,610,784

 

144,765,808

 


Derivative financial instruments

 

877,137

 

225,376

 


Investments


 

 


 


- Financial Assets at Fair Value through P&L

13

1,648

 

240,987

 


- Financial Assets at Fair Value through OCI

13

215,842,642

 

192,390,931

 


- Financial Assets at Amortized cost

13

19,723,117

 

20,318,767

 


- Investments in associates and subsidiaries

14

1,064,250

 

1,014,350

 


Other assets

15

11,626,924

 

11,141,917

 


Deferred tax assets (Liabilities)

 

354,638

 

460,026

 


Property and equipment

16

2,391,033

 

2,404,237

 


Total assets

 

521,616,413

 

496,651,124

 


Liabilities and equity


 

 


 


Liabilities


 

 


 


Due to banks

17

2,969,822

 

862,759

 


Due to customers

18

427,556,083

 

406,100,916

 


Derivative financial instruments

 

34,934

 

265,265

 


Current income tax liabilities


2,330,166

 

2,234,985

 


Other liabilities

19

9,972,432

 

8,021,310

 


Issued debt instruments

20

1,864,924

 

1,557,263

 


Other loans

 

5,987,651

 

5,140,782

 


Other Provisions

21

5,355,635

 

3,539,676

 


Total liabilities

 

456,071,647

 

427,722,956

 


Equity

 

 

 


 


Issued and paid up capital

 

19,825,134

 

19,702,418

 


Reserves


36,022,139

 

33,767,423

 


Reserve for employee stock ownership plan (ESOP)

 

1,555,725

 

1,674,392

 


Retained earnings *

 

8,141,768

 

13,783,935

 


Total equity and net profit for the period / year

 

65,544,766

 

68,928,168

 


Total liabilities and equity

 

521,616,413

 

496,651,124

 




 

 


 



 




 

 

 

 


 


 


 



 







 


The accompanying notes are an integral part of these financial statements.

 




 

 

(Review report attached)

 




 


* Including net profit for the current period

 




 





 







 





 





 


Hussein Abaza

Sherif Samy

 

CEO & Managing Director


Chairman













 



 

 

 




 

 



 

 

 

 


 






















 


 





 

Condensed Separate Interim Income Statement for the period ended June 30, 2022

 




 

 



 


Notes

 

 

Jun. 30, 2022

 


Jun. 30, 2021

 

 




EGP Thousands

 


EGP Thousands

 

 




 

 



 

 

Interest and similar income



24,258,160

 


20,975,491


 

Interest and similar expense



(10,562,668)

 


(9,302,462)


 

Net interest income



13,695,492

 


11,673,029


 

 



 

 




 

Fee and commission income



2,408,556

 


1,798,447


 

Fee and commission expense



(1,072,802)

 


(687,129)


 

Net fee and commission income



1,335,754

 


1,111,318


 

 



 

 




 

Dividend income

 


62,799

 


63,572


 

Net trading income

5

 

1,013,504

 


274,657


 

Profits (Losses) on financial investments

13

 

1,065,443

 


577,519


 

Administrative expenses

 


(3,233,444)

 


(2,918,943)


 

Other operating (expenses) income

6


(2,509,857)

 


(1,113,292)


 

Impairment release (charges) for credit losses

 

 

(14,449)

 


(1,019,076)


 

Profit before income tax


 

11,415,242

 


8,648,784


 

 



 

 




 

Income tax expense

25


(3,110,536)

 


(2,590,270)


 

Deferred tax assets (Liabilities)

25


(530,715)

 


18,828


 

Net profit for the period

 


7,773,991

 


6,077,342


 

 



 

 




 

Earning per share

7


 

 




 

Basic



3.48

 


2.75


 

Diluted



3.44

 


2.71


 




 

 




 


 


 

 




 

 

 

 

 

 




 

 

 

 


 

 








 

 





















































 

Hussein Abaza






CEO & Managing Director

 




Sherif Samy

 








Chairman

















 





 

 


 








 







Condensed Separate Interim statement of Comprehensive Income for the period ended June 30, 2022

 



 

 



 




Jun. 30, 2022

 


Jun. 30, 2021


 




EGP Thousands

 


EGP Thousands


 




 

 




 

Net profit for the period

 


7,773,991

 


6,077,342


 

 



 

 




 

Change in fair value of debt instruments measured at fair value through other comprehensive income after income tax



(7,358,230)

 


(1,624,416)


 

Transferred from reserve on disposal of financial assets at fair value through OCI



(4,227)

 


(104,406)


 

Effect of ECL in fair value of debt instruments measured at fair value through OCI



104,188

 


(54,113)


 

Total comprehensive income for the period



515,722

 


4,294,407


 

 

 


 

 




 

 



 





 




 





 




 





 




 





 

 



 





 

 



 





 

 



 

 




 




 

 




 

 

 


 

 




 


 








 



 





 








 

Condensed Separate Interim Cash flows for the period ended June 30, 2022

 







 

Notes

Jun. 30, 2022

 

Jun. 30, 2021




EGP Thousands

 

EGP Thousands




 

 


Cash flow from operating activities



 

 


Profit before income tax



11,415,242

 

8,648,784

Adjustments to reconcile net profit to net cash provided by operating  activities



 

 


Fixed assets depreciation

 

16

427,873

 

411,612

Impairment charge for credit losses (Loans and advances to customers and banks)

 

 

(94,868)

 

1,060,008

Other provisions charges

 

21

1,513,984

 

350,323

Impairment charge for credit losses (due from banks)

 

 

5,357

 

13,181

Impairment (Released) charge for credit losses (financial investments)



103,960

 

(54,113)

Impairment (Released) charge for other assets



(277,768)

 

25,524

Exchange revaluation differences for financial assets at fair value through OCI and AC



(2,840,747)

 

50,039

Impairment (Released) charge financial assets at fair value through OCI



-

 

(72,957)

Utilization of other provisions

 

21

(1,707)

 

(44,173)

Other provisions no longer used

 

21

(267)

 

(9,145)

Exchange differences of  other provisions

 

21

303,949

 

(9,196)

Losses (profits) from selling property and equipment

 

 

(1,142)

 

(1,250)

Losses (profits) from selling financial investments

 

13

(1,065,443)

 

(514,837)

Shares based payments

 

 

384,255

 

316,514

Impairment (Released) charges of investments in associates and subsidiaries



-

 

10,275

Operating losses (profits) before changes in operating assets and liabilities



9,872,678

 

10,180,589

 



 

 


Net decrease (increase) in assets and  liabilities



 

 


Due from banks



13,240,715

 

(8,642,436)

Financial assets at fair value through P&L

 

13

239,339

 

151,530

Derivative financial instruments

 

 

(882,092)

 

(19,897)

Loans and advances to banks and customers

 

11 - 12

(25,746,135)

 

(12,680,083)

Other assets

 

 

(291,414)

 

(1,944,779)

Due to banks

 

17

2,107,063

 

(7,502,230)

Due to customers

 

18

21,455,167

 

44,869,003

Current income tax obligations paid

 

 

(780,370)

 

(973,779)

Other liabilities

 

 

(283,863)

 

794,030

Net cash used in (generated from) operating activities

 

 

18,931,088

 

24,231,948

 



 

 


Cash flow from investing activities



 

 


Proceeds (payments) for investment in associates.



(49,900)

 

(158,360)

Payment for purchases of property, equipment and branches  constructions



(312,818)

 

(522,975)

Proceeds from selling property and equipment



1,142

 

1,250

Proceeds from redemption of financial assets at amortized cost



659,761

 

2,654,583

Payment for purchases of financial assets at amortized cost



(41,770)

 

(3,844)

Payment for purchases of financial assets at fair value through OCI



(67,627,930)

 

(111,506,191)

Proceeds from selling financial assets at fair value through OCI



45,512,886

 

71,451,202

Net cash generated from (used in) investing activities



(21,858,629)

 

(38,084,335)

 



 

 





 

 


 

 

 

 

 





 

 


 



 

 
















 

Condensed Separate Interim Cash flows for the period ended June 30, 2022 (Cont.)

 








Jun. 30, 2022

 

Jun. 30, 2021

 



EGP Thousands

 

EGP Thousands

 



 

 


 

Cash flow from financing activities


 

 


 

Increase (decrease) in long term loans


846,869

 

(2,120,154)

 

Dividend paid


(4,410,322)

 

(1,360,652)

 

Increase (decrease) in issued debt instruments


307,661

 

-

 

Capital increase


122,716

 

-

 

Net cash generated from (used in) financing activities


(3,133,076)

 

(3,480,806)

 

 


 

 


 



 

 


 

Net (decrease) increase in cash and cash equivalent during the period


(6,060,617)

 

(17,333,193)

 

Beginning balance of cash and cash equivalent


60,891,899

 

75,965,247

 

Cash and cash equivalent at the end of the period


54,831,282

 

58,632,054

 

 


 

 


 

Cash and cash equivalent comprise:


 

 


 

Cash and balances at the central bank


41,845,093

 

31,792,597

 

Due from banks


57,016,700

 

79,116,502

 

Treasury bills and other governmental  notes

10

76,375,291

 

58,677,132

 

Obligatory reserve balance with CBE

 

(36,065,936)

 

(26,239,755)

 

Due from banks with maturities more than three months


(12,494,125)

 

(26,293,821)

 

Treasury bills with maturity more than three months


(71,845,741)

 

(58,420,601)

 

Total cash and cash equivalent


54,831,282

 

58,632,054

 











'

 

 

 

 

 
















 

Condensed Separate Interim statement of  changes in shareholders' equity  for the period ended June 30, 2021

 




Jun. 30, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total
















EGP Thousands






Beginning balance

  14,776,813

  2,778,135

  24,765,658

  1,549,445

  14,906

  3,970,987

  6,423

  10,477,611

  1,064,648

  59,404,626






Capital increase

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 






Transferred to reserves

  - 

  514,939

  8,420,479

  - 

  1,094

  - 

  - 

  (8,936,512)

  - 

  - 





Dividend paid

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  (1,360,652)

  - 

  (1,360,652)






Net profit of the year

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  6,077,342

  -  

  6,077,342






Transferred from reserve of financial assets at fair value through OCI

  - 

  - 

  - 

  - 

  - 

  (104,406)

  -   

  104,406

  - 

  - 






Transferred from previous years' outstanding balances

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  8,333

  - 

  8,333






Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

  - 

  - 

  - 

  - 

  - 

  (1,624,416)

  - 

  - 

  - 

  (1,624,416)






Transferred (from) to bank risk reserve

  - 

  - 

  - 

  - 

  - 

  - 

  2,718

  (2,718)

   - 

  - 






Effect of ECL in fair value of debt instruments measured at fair value through OCI

  - 

  - 

  - 

  - 

  - 

  (54,113)

  - 

  - 

  - 

  (54,113)






Cost of employees stock ownership plan (ESOP)

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  316,514

  316,514






Ending balance

  14,776,813

  3,293,074

  33,186,137

  1,549,445

  16,000

  2,188,052

  9,141

  6,367,810

  1,381,162

  62,767,634






















































































 

 

 

 

Condensed Separate Interim statement of  changes in shareholders' equity for the period ended June 30, 2022

 




 

 




Jun. 30, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 


 










EGP Thousands

 





Beginning balance

  19,702,418

  3,293,074

  28,260,532

  1,549,445

  16,000

  639,231

  9,141

  13,783,935

  1,674,392

  68,928,168

 

 

 

 


Capital increase

  122,716

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 

   122,716

 

 

 

 


Transferred to reserves

  - 

  670,872

  8,836,326

  - 

  2,947

  - 

  - 

  (9,007,223)

  (502,922)

  - 

 

 

 

 

Dividend paid

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  (4,410,322)

  - 

  (4,410,322)

 

 

 

 

Net profit of the year

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  7,773,991

  - 

  7,773,991

 

 

 

 


Transferred from reserve on disposal of financial assets at fair value through OCI

  - 

  - 

  - 

  - 

  - 

  (4,227)

  - 

  4,227

  - 

  - 

 

 

 

 


Transferred from previous years' outstanding balances

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 

 

 

 

 


Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

  - 

  - 

  - 

  - 

  - 

  (7,358,230)

  - 

  - 

  - 

  (7,358,230)

 

 

 

 


Transferred (from) to banking risk reserve

  - 

  - 

  - 

  - 

  - 

  - 

  2,840

  (2,840)

  - 

  - 

 

 

 

 


Effect of ECL in fair value of debt instruments measured at fair value through OCI

  - 

  - 

  - 

  - 

  - 

  104,188

   - 

  - 

  - 

  104,188

 

 

 

 


Cost of employees stock ownership plan (ESOP)

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  - 

  384,255

  384,255

 

 

 

 


Ending balance

  19,825,134

  3,963,946

  37,096,858

  1,549,445

  18,947

  (6,619,038)

  11,981

  8,141,768

  1,555,725

  65,544,766

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 














 


















 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DGGDRLUDDGDS
UK 100

Latest directors dealings